These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22774207)

  • 1. GLP-1 and glucagon secretion from a pancreatic neuroendocrine tumor causing diabetes and hyperinsulinemic hypoglycemia.
    Roberts RE; Zhao M; Whitelaw BC; Ramage J; Diaz-Cano S; le Roux CW; Quaglia A; Huang GC; Aylwin SJ
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3039-45. PubMed ID: 22774207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction.
    Rabiee A; Magruder JT; Salas-Carrillo R; Carlson O; Egan JM; Askin FB; Elahi D; Andersen DK
    J Surg Res; 2011 May; 167(2):199-205. PubMed ID: 21414635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synchronous Nesidioblastosis, Endocrine Microadenoma, and Intraductal Papillary Mucinous Neoplasia in a Man Presenting With Hyperinsulinemic Hypoglycemia.
    De Sousa SM; Haghighi KS; Qiu MR; Greenfield JR; Chen DL
    Pancreas; 2016 Jan; 45(1):154-9. PubMed ID: 26658039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet cell tumor with hypoglycemia.
    Remigio PA; Grinvalsky HT
    Am Fam Physician; 1971 Mar; 3(3):98-101. PubMed ID: 4323689
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucagon-secreting pancreatic islet cell carcinoma, containing insulin and somatostatin, with hypoglycemic attack.
    Yano T; Yamamoto N; Fujimori K; Inamori S; Hayashi H; Mizumoto R
    Am J Gastroenterol; 1982 Jun; 77(6):387-91. PubMed ID: 6124121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
    Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
    Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.
    Nauck MA; Heimesaat MM; Behle K; Holst JJ; Nauck MS; Ritzel R; Hüfner M; Schmiegel WH
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1239-46. PubMed ID: 11889194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin and somatostatin releasing islet cell tumor caused hypoglycemia.
    Karasawa Y; Mochizuki T; Kawa S; Aoki Y; Ueno T; Watanabe T; Kawasaki S; Miyagawa S; Itoh N; Tamai C; Sakurai A; Kiyosawa K
    Intern Med; 2001 Apr; 40(4):324-30. PubMed ID: 11334393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cure of hypoglycemic hyperinsulinism by enucleation of a focal islet cell adenomatous hyperplasia.
    Craver RD; Hill CB
    J Pediatr Surg; 1997 Oct; 32(10):1526-7. PubMed ID: 9349791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial hypoglycemia in islet beta cell hyperplasia with adenomatosis of the pancreas.
    Tibaldi JM; Lorber D; Lomasky S; Steinberg JJ; Reisman R; Shamoon H
    J Surg Oncol; 1992 May; 50(1):53-7. PubMed ID: 1573895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLP-1 metabolite GLP-1(9-36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion.
    Gandasi NR; Gao R; Kothegala L; Pearce A; Santos C; Acreman S; Basco D; Benrick A; Chibalina MV; Clark A; Guida C; Harris M; Johnson PRV; Knudsen JG; Ma J; Miranda C; Shigeto M; Tarasov AI; Yeung HY; Thorens B; Asterholm IW; Zhang Q; Ramracheya R; Ladds G; Rorsman P
    Diabetologia; 2024 Mar; 67(3):528-546. PubMed ID: 38127123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients.
    Rickels MR; Mueller R; Markmann JF; Naji A
    J Clin Endocrinol Metab; 2009 Jan; 94(1):181-9. PubMed ID: 18957498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exendin-(9-39) corrects fasting hypoglycemia in SUR-1-/- mice by lowering cAMP in pancreatic beta-cells and inhibiting insulin secretion.
    De León DD; Li C; Delson MI; Matschinsky FM; Stanley CA; Stoffers DA
    J Biol Chem; 2008 Sep; 283(38):25786-93. PubMed ID: 18635551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromanol 293B, an inhibitor of KCNQ1 channels, enhances glucose-stimulated insulin secretion and increases glucagon-like peptide-1 level in mice.
    Liu L; Wang F; Lu H; Ren X; Zou J
    Islets; 2014; 6(4):e962386. PubMed ID: 25437377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-secreting islet cell tumors: establishing a diagnosis and the clinical course for 25 dogs.
    Kruth SA; Feldman EC; Kennedy PC
    J Am Vet Med Assoc; 1982 Jul; 181(1):54-8. PubMed ID: 6286582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neonatal hypoglycemia due to hyperinsulinism secondary to Langerhans' polyadenomatosis. Recovery after pancreatectomy].
    Babinet JM; Labrune B; Vignes B; Thibaud D; Valayer J; Tichet J; Gubler JP
    Arch Fr Pediatr; 1975; 32(6):515-31. PubMed ID: 170877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K+ channel.
    Calabria AC; Li C; Gallagher PR; Stanley CA; De León DD
    Diabetes; 2012 Oct; 61(10):2585-91. PubMed ID: 22855730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
    Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
    Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.